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MiceDrug-induced behavioral sensitization in rodents has enhanced our understanding of why drugs acquire
increasing motivational and incentive value. Compared to adults, human adolescents have accelerated
dependence courses with shorter times from ﬁrst exposure to dependence. We compared adolescent and
adult mice in their ability to develop behavioral sensitization to amphetamine following a single injection.
Adult (90-day-old) and adolescent (45-day-old) male Swiss mice received an acute intraperitoneal injection
of saline or amphetamine (1.0, 2.0 or 4.0 mg/kg). Seven days later, half of the mice from the saline group
received a second injection of saline. The remaining animals were challenged with 2.0 mg/kg amphetamine.
Following all of the injections, mice were placed in activity chambers and locomotion was quantiﬁed for
45 min. The magnitude of both the acute and sensitized locomotor stimulatory effect of amphetamine was
higher in the adolescent mice. Previous experience with the test environment inhibited the acute
amphetamine stimulation in both adolescent and adult mice, but facilitated the detection of elevated
spontaneous locomotion in adolescent animals. These results support the notion that the adolescent period is
associated with an increased risk for development of drug abuse. Additionally, they indicate a complex
interaction between the environmental novelty, adolescence and amphetamine.logia, Universidade Federal de
1° andar, 04023062, São Paulo,
49 4122x222.
gmail.com (R. Frussa-Filho).
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Behavioral sensitization has been characterized by a progressive
increase in drug-elicited behavioral responses in rodents following
repeated administration (Robinson and Becker, 1986). Sensitization
to drug-induced hyperlocomotion in rodents has become dominant
over other behavioral parameters in neuropsychopharmacological
studies because it is useful for studying mechanisms of plasticity in
the dopaminergic mesoaccumbens pathway (Henry andWhite, 1991;
Wolf et al., 1994), which is linked to the development of drug cravings
in humans. Indeed, the activity of the mesolimbic dopaminergic
system is a key component in the chain of events that leads from the
molecular action of drugs of abuse to the establishment of drug
addiction (Robinson and Berridge, 1993, 2008; Vezina, 2004).Importantly, it has been demonstrated that it is not necessary to
repeatedly administer amphetamine for long periods of time to produce
behavioral sensitization. Indeed, a single pre-treatment with amphet-
amine has been reported to enhance both stereotypy (Browne and
Segal, 1977; Chinen et al., 2006) and locomotor stimulation (Alvarez
et al., 2006; Calzavara et al., 2008; Chinen et al., 2006; Vanderschuren
et al., 1999) produced by an injection of amphetamine given hours, days
or weeks after the ﬁrst injection. This suggests that a single injection
of amphetamine is sufﬁcient to elicit an immediate and long lasting
sensitization of the neuronal dopaminergic mechanisms related to drug
craving.
Adolescence is characterized by a heightened risk for the develop-
ment of substance abuse (Laviola et al., 1999; Spear, 2000; Wahlstrom
et al., 2010). In apparent contrast with these clinical data there is a large
literature showing that adolescent rodents exhibit lower or lack of
locomotor sensitization compared to adults in response to repeated
psychostimulants, nicotine or ethanol (Collins and Izenwasser, 2002;
Cruz et al., 2005; Faria et al., 2008; Frantz et al., 2007; Kolta et al., 1990;
Laviola et al., 1999;McDougall et al., 1994; Tirelli et al., 2003;Ujike et al.,
1995). However, in the only study performed to compare single
injection-induced behavioral sensitization in adolescent and adult
Fig. 1. Mean (±SEM) locomotion frequency (number of horizontal beam breaks/
45 min) during pre-treatment with saline or 1.0, 2.0 or 4.0 mg/kg amphetamine in adult
and adolescent mice (session 1). Data were analyzed by two-way ANOVA followed by
Duncan's test. ○ pb0.05 compared to the group of the same age but acutely treated
with saline (Sal). # pb0.05 compared to the group of the same age but acutely treated
with 1.0 mg/kg amphetamine (Amph1). ● pb0.05 compared to the group of the same
age but acutely treated with 2.0 mg/kg amphetamine (Amph2). + pb0.05 compared to
adult mice with the same drug treatment.
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in adolescent rats. From a clinical point of view, this ﬁnding is in
accordance with reports that adolescent humans go from ﬁrst drug
exposure todependence in amuch shorter timeframe than adults (Clark
et al., 1998; Estroff et al., 1989). From a basic point of view, it is in line
with recent evidence highlighting molecular divergences between
single injection-induced sensitization and the classical sensitization
induced by repeated injections (Valjent et al., 2010). Thus, it is
important to conﬁrm the higher sensitivity of adolescent subjects to
single injection-induced sensitization to other drugs of abuse and in a
different rodent species.
The aim of the present study is to compare single injection-
induced sensitization to the locomotor stimulatory effect of amphet-
amine in adolescent and adult mice.
2. Methods
2.1. Subjects
Adult (90-day-old) and adolescent (45-day-old) Swiss EPM-M1
malemice from a lab-operated breeding colonywere housed 9–10 per
cage in polypropylene cages (41 cm×34 cm×16 cm). Each cage
contained animals from the same experimental group. The vivarium
was maintained at 22–23 °C with a 12-h light/dark cycle (lights on at
06:45 h). Food and water were available ad libitum throughout the
experiment.
The age for adolescent mice was chosen based on a review by
Laviola et al. (2003), which reported three age-intervals for
adolescence in rodents. Since the adolescent period is quite short
in rodents, we chose to start behavioral testing during what is
considered to be the middle-adolescence/periadolescent period
(post-natal day—PND—34 to 46). Adolescent mice were tested at
45–51 days of age and adult mice were tested at 90–96 days of age.
The experimental protocol was approved by the Committee for the
Use of Animal Subjects from our Institution (Universidade Federal de
São Paulo—UNIFESP). The animals used in this study were maintained
in accordance with the guidelines of the National Institutes of Health
Guide for Care and Use of Laboratory Animals (Publication No. 85-23,
revised 1985). All efforts were taken to minimize pain and discomfort
of the animals throughout the course of the study.
2.2. Drugs
D-Amphetamine (SIGMA®) was diluted in saline. A saline injection
was used as the control solution. The solutions were delivered
intraperitoneally (ip) at a volume of 10 ml/kg body weight.
2.3. Behavioral testing
Activity was recorded in ten identical activity monitoring chambers
consisting of transparent Plexiglas boxes (45×45×34.5 cm high)
equipped with 16 infrared light emitters and detectors placed 4 cm
above the ﬂoor (Insight Instruments, Brazil). Thesewere connected to a
microcomputer that counted the number of times the photo beams
were broken. The total number of horizontal beambreaks was used as a
measure of locomotion. Animals were placed in the activity chambers
immediately after being injected with saline or amphetamine and their
locomotion was monitored for 45 min. Animals of both ages were
alternatedwhen locomotor activitywas recorded. All behavioral testing
was done between 13:00 and 17:00.
2.4. Experimental procedure
Adult (90-day-old) and adolescent (45-day-old)mice received an ip
injection of saline (Sal) or amphetamine at doses of 1.0 (Amph1),
2.0 (Amph2) or 4.0 (Amph4)mg/kg. Activity was measured for 45 minpost-injection to evaluate the locomotor stimulant effect of amphet-
amine (session 1). For session 1, animalswere divided into eight groups:
Adult-Sal (N=18), Adult-Amph1 (N=9), Adult-Amph2 (N=10),
Adult-Amph4 (N=10), Adolescent-Sal (N=19), Adolescent-Amph1
(N=10), Adolescent-Amph2 (N=10) and Adolescent-Amph4
(N=10).
Seven days after the initial injection, mice received a challenge
injection of either saline (-Sal) or 2.0 mg/kg amphetamine (-Amph) to
assess behavioral sensitization (session 2). Thus, the following groups
were formed in session 2: Adult-Sal-Sal (N=9), Adult-Sal-Amph
(N=9), Adult-Amph1-Amph (N=9), Adult-Amph2-Amph (N=10),
Adult-Amph4-Amph (N=10), Adolescent-Sal-Sal (N=10), Adolescent-
Sal-Amph (N=9), Adolescent-Amph1-Amph (N=10), Adolescent-
Amph2-Amph (N=10) and Adolescent-Amph4-Amph (N=10). After
the challenge injection, locomotor activity was monitored for 45 min.
2.5. Statistical analysis
Data from session 1 were analyzed by a 2×4 (age×treatment
factors) two-way ANOVA and data from session 2 were analyzed by a
2×5 (age×treatment-challenge factors) two-way ANOVA. Multiple
comparisons were performed using the Duncan's post-hoc test when
necessary. Statistical signiﬁcance was deﬁned as Pb0.05.
3. Results
Fig. 1 shows the session 1 locomotion frequencies of adult and
adolescent mice after acute administration of saline or amphetamine
(1.0, 2.0 or 4.0 mg/kg). A two-way ANOVA revealed signiﬁcant effects
of age (adult×adolescent) [F(1,88)=15.7, Pb0.05] and acute treat-
ment (Sal×Amph1×Amph2×Amph4) [F(3,88)=143.8, Pb0.05].
There was also a signiﬁcant interaction between age and acute
treatment [F(3,88)=6.1, Pb0.05]. A Duncan's test showed that acute
administration of amphetamine produced a signiﬁcant increase in
locomotion in both adult and adolescent mice, however, this effect
was only observed at the 2.0 and 4.0 mg/kg doses. The enhancement
in locomotion was dose-dependent (Amph4NAmph2) regardless of
age. Importantly, adolescent mice had signiﬁcantly greater locomotor
activity than adult mice given 1.0 or 2.0 mg/kg amphetamine.
Fig. 2 shows the locomotion frequencies of adult and adolescent
mice after a saline or amphetamine (2.0 mg/kg) challenge injection
(session 2) administered 7 days after session 1. A two-way ANOVA
Fig. 2. Mean (±SEM) locomotion frequency (number of horizontal beam breaks/
45 min) during amphetamine challenge (session 2) in adult and adolescent mice 7 days
after pre-treatment with saline or one of the three different doses of amphetamine.
○ pb0.05 compared to the group of the same age but treated and challenged with saline
(Sal-Sal). □ pb0.05 compared to the group of the same age but treated with saline and
challenged with 2.0 mg/kg amphetamine (Sal-Amph). # pb0.05 compared to the group
of the same age but treated with 1.0 mg/kg amphetamine and challenged with 2.0 mg/
kg amphetamine (Amph1-Amph).● pb0.05 compared to the group of the same age but
treated and challenged with 2.0 mg/kg amphetamine (Amph2-Amph). + pb0.05
compared to adult mice with the same drug treatment and challenge.
322 S.R. Kameda et al. / Pharmacology, Biochemistry and Behavior 98 (2011) 320–324revealed signiﬁcant effects of age (adult×adolescent) [F(1,86)=
164.1, Pb0.05] and treatment-challenge (Sal-Sal×Sal-Amph×
Amph1-Amph×Amph2-Amph×Amph4-Amph) [F(4,86)=134,
Pb0.05]. There was also a signiﬁcant interaction between these two
factors [F(4,86)=8.7, Pb0.05]. Unlike session 1, acute administration
of 2.0 mg/kg amphetamine did not affect locomotion of adult or
adolescent mice during session 2 (Sal-Sal=Sal-Amph). The Duncan's
test showed that, in contrast to session 1, adolescent mice had a
signiﬁcantly higher frequency of spontaneous locomotion than
adult controls in session 2 (Adolescent-Sal-SalNAdult-Sal-Sal). In
addition, only mice pre-treated with 2.0 or 4.0 mg/kg amphetamine
developed behavioral sensitization regardless of age (Amph2-Amph
and Amph4-AmphNSal-Amph). Although the magnitude of behavioral
sensitization did not vary across the amphetamine pre-treatment doses
in adolescent mice, adults pre-treated with 4.0 mg/kg amphetamine
displayed enhanced behavioral sensitization. Regardless of the amphet-
amine pre-treatment dose, the magnitude of behavioral sensitization
was signiﬁcantly greater in adolescent than in adult mice.
4. Discussion
The main ﬁndings of the present study are: 1) adolescent mice are
more sensitive to the locomotor stimulatory effect induced by acute
administration of moderate, but not high, doses of amphetamine;
2) both adolescent and adult mice exhibited locomotor sensitization
to amphetamine after a single injection, but adolescent mice showed a
higher magnitude of sensitization; 3) the acute locomotor stimulatory
effect of a moderate (2.0 mg/kg) dose of amphetamine was abolished
by previous experience with the test environment in both adolescent
and adult mice; and 4) previous experiencewith the test environment
facilitated the detection of increased spontaneous locomotor activity
in adolescent mice as compared to adult mice.
Although acute administration of a high dose of amphetamine
(4.0 mg/kg) resulted in a similar increase in locomotor activity
regardless of age, adolescent mice were more sensitive than adults
to the locomotor-stimulating effect of a moderate amphetamine dose(2.0 mg/kg). Additionally, while the 1.0 mg/kg dose of amphetamine
did not produce locomotor stimulation in adolescent and adult mice,
there was a trend in this direction in adolescent mice. This trend
resulted in a signiﬁcantly higher locomotor activity in amphetamine-
treated adolescents when compared to amphetamine-treated adult
mice. Thus, there was a leftward shift in the amphetamine dose–
response curve in adolescent mice, indicating an increased sensitivity
to the locomotor-stimulating effect during this age period.
There is controversy regarding the sensitivity of adolescent and
adult rodents to the acute locomotor-stimulating effect of psychos-
timulants. For example, several investigations indicate that adolescent
rodents are less responsive than older counterparts to the acute
locomotor-activating effects of amphetamine or cocaine (Bolanos
et al., 1998; Lanier and Isaacson, 1977; Laviola et al., 1995, 1999,
2003). In contrast, adolescent rodents have been reported to be more
sensitive (Badanich et al., 2008; Maldonado and Kirstein, 2005a,b) or
to show the same sensitivity (Camarini et al., 2008; Niculescu et al.,
2005) to the acute locomotor-stimulating effect of psychostimulants.
These contradictory ﬁndings can be explained by differences in
behavioral analyses, such as handling (see Maldonado and Kirstein,
2005a,b), duration of the observation session or previous exposure to
the test environment (Niculescu et al., 2005). Differences in the
experimental design, such as stage of adolescence [i.e., early (PND 24
to 35), middle (PND 37 to 48) or late (PND 50 to 61) adolescence—see
Adriani et al., 2002] and species chosen, may also explain the
discrepancies found in the literature (Badanich et al., 2008).
Differences among laboratory animal housing conditions should also
be considered. Indeed, we have previously demonstrated that mice
housed in groups of 15 exhibit greater ethanol-induced locomotor
sensitization than mice housed in groups of 5 or in isolation (Araujo
et al., 2005).
Interestingly, in terms of neurochemical effects, age-related
differences in dopaminergic responses to acute amphetamine or
cocaine administration have been reported and the literature is also
inconsistent. For example, adolescent rodents have been reported to
be less (Cao et al., 2007; Laviola et al., 2001) or more (Stansﬁeld and
Kirstein, 2006) sensitive to the ability of psychostimulants to elevate
extracellular levels of dopamine in the striatum/nucleus accumbens as
compared to adults. Additionally, Camarini et al. (2008) did not ﬁnd
signiﬁcant differences in acute cocaine-induced increases in extracel-
lular levels of dopamine in the nucleus accumbens of adolescent and
adult mice.
In the present study, adolescent mice have higher sensitivity to the
locomotor-activating effect of amphetamine. Following the acute
administration of a high dose of amphetamine, Adriani and Laviola
(2000) also veriﬁed a marked locomotor activity in periadolescent rats
(PND 33–43) and enhanced stereotyped behaviors in adult counter-
parts. Increased sensitivity to the locomotor stimulatory effect of
amphetamine in adolescent mice is in line with an increased risk of
developing drug abuse behaviors and drug-related problems associated
with the adolescent period in humans (Chambers et al., 2003; Compas
et al., 1995; Spear, 2000;Wahlstrom et al., 2010). The body of evidence
points to the importance of activation of themesoaccumbens dopamine
pathway in both drug-induced locomotor stimulation in rodents and
reward in both rodents and humans (Di Chiara and Imperato, 1988;
Dreher et al., 2009; Koob, 1992; Self and Nestler, 1995; Wheeler and
Carelli, 2009). Supporting this notion, our study shows that adolescent
mice have a higher magnitude of locomotor sensitization induced by
a single injection of amphetamine when compared to adults. As
mentioned previously, sensitization to the locomotor stimulatory effect
of drugs of abuse in rodents is believed to be a useful model to study
the mechanisms underlying drug craving in humans (Robinson and
Berridge, 1993). Both behavioral phenomena seem to share plastic
mechanisms in the mesolimbic dopamine system (Alcaro et al., 2007;
Araujo et al., 2009; Costa et al., 2007; Henry et al., 1989; Nestler, 2004;
Volkow et al., 2002; White and Wang, 1984).
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Introduction), behavioral sensitization produced by repeated treatment
with psychostimulants is greater in adults than in adolescent rodents.
Following a single drug exposure, however, Caster et al. (2007) have
observed enhanced locomotor sensitization to cocaine in adolescent rats
when compared to adults. Similarly, we demonstrated herein that
adolescent mice present increased locomotor sensitization to amphet-
amine treatment with a single injection protocol. Although the
molecular mechanisms underlying sensitization are largely unknown,
there is evidence to suggest that sensitization to repeated psychosti-
mulant injections is less reliably dependent on the dopamine D1
receptor than sensitization to a single injection of these drugs (see
Valjent et al., 2010). Within this context, while the phosphoprotein
DARPP-32 has been shown to play a role as an ampliﬁer of thedopamine
D1 signaling pathway (Valjent et al., 2010), sensitization to repeated
injections of cocaine was increased (Hiroi et al., 1999), whereas
sensitization to a single injection of cocaine was reduced in DARPP-32
knockout mutant mice (Valjent et al., 2005). Importantly, the
percentage of prefrontal cortex pyramidal cells that project to the
nucleus accumbens containing dopamine D1 receptors peaks at levels
that are notably higher late in adolescence (N40%) than in younger or
older animals (b4–5%) (see Doremus-Fitzwater et al., 2010 for a recent
review). These ﬁndings are intriguing given the importance of
prefrontal cortex projections to the nucleus accumbens in drug seeking
(Kalivas et al., 2005). Also relevant to this issue is that D1 receptors have
been reported to be present at a higher density in the striatum area at
PND 40 than at PND 80 in rats (Andersen and Teicher, 2000).
The aforementioned considerations of the molecular mechanisms
by which adolescent rodents are more sensitive than adults to
psychostimulant-induced locomotor sensitization after a single
injection protocol but less sensitive (in the great majority of the
studies) after repeated injections are speculative, and further work is
clearly required to characterize the substrates involved. It should also
be noted that some studies have reported increased locomotor
sensitization to psychostimulants in adolescent rodents when
compared to adults, even after the classical repeated injection
protocol (Adriani et al., 1998; Camarini et al., 2008; Laviola et al.,
1995). Importantly, Laviola et al. (1995) have reported that
adolescent rats showed greater sensitization to the locomotor-
activating effects of repeated administration of cocaine, whereas
adults presented a consistent sensitization proﬁle for stereotyped
behaviors. This controversy notwithstanding, the ﬁndings that
adolescent rodents show higher sensitization to the locomotor-
activating effect after a single injection of cocaine (Caster et al.,
2007) or amphetamine (present study) appear to be in accordance
with reports that adolescent humans progress from the ﬁrst drug
exposure to dependence in a much shorter timeframe than adults
(Clark et al., 1998). However, one must always be wary of
extrapolating clinical relevance from animal data.
Two additional interestingﬁndings involve the inﬂuence of previous
experience with the test environment on both amphetamine and
adolescence effects onmouse locomotor activity. First, in both adult and
adolescent mice, the locomotor-activating effect of a moderate dose
(2.0 mg/kg) of amphetamine was detected only in the ﬁrst session,
when the test environment was completely novel. These results are
consistent with studies using other psychostimulant drugs, such as
cocaine (Carey et al., 2005) and apomorphine (Montanaro et al., 1983).
Carey et al. (2005) stated that the dose of cocaine required to evoke
locomotor stimulation in a novel environment elicits substantially less
locomotor stimulation after familiarization with the test environment.
Within this context, environmental novelty provokes dopamine release
in the nucleus accumbens (Rebec et al., 1997) and can potentiate the
motivational effects of addictive drugs (Alvarez et al., 2006; Fukushiro
et al., 2010; Fukushiro and Frussa-Filho, 2010). Notably, familiarization
with the test environment did not decrease the response to a second
administration of 2.0 mg/kg amphetamine when mice had been pre-treated with the psychostimulant at the doses of 2.0 and 4.0 mg/kg.
Because theseprimingdoses of amphetaminehad the ability topromote
sensitization (as demonstrated by the signiﬁcantly higher locomotor
activity of theAmph2-AmphandAmph4-Amphgroupswhencompared
to the Sal-Amph group in session 2—see Fig. 2) one might suggest that
the sensitization phenomenon avoided the expression of the familiar-
ization effects.
On the other hand, by using t-tests to analyze the paired samples,
we found a signiﬁcant decrease in the locomotion frequency of the
Sal-Sal and Amph2-Amph groups in session 2 as compared to session
1. Thus, another possibility is that familiarization with the test
environment attenuated the expression of amphetamine-induced
behavioral sensitization in the Amph2-Amph groups. We should also
highlight the importance of environmental context in the develop-
ment of behavioral sensitization. In this regard, Laviola et al. (1995)
have demonstrated that behavioral sensitization to cocaine developed
only when the drug was administered in the test environment; in
addition, they have shown that the development of this sensitization
was a function of age-speciﬁc alterations in sensitivity of rats to
psychostimulants. In the present study, the adult and adolescent
mice received amphetamine injections always paired with the test
environment. Therefore, the conditioning effects of the context-
dependent amphetamine-induced behavioral sensitization may also
account for the present data.
Second, previous experience with the test environment facilitated
the detection of an increased spontaneous locomotor activity in
adolescents. These results are in accordance with data from Adriani
and Laviola (2000) who demonstrated that adolescent mice displayed
higher activity levels than adults only near the end of a 120-min
session in activity chambers. The authors concluded that adolescent
mice exhibit a reduced habituation to the novel environment. This
reduced habituation might justify the elevated basal levels of
locomotion (i.e., in response to saline) presented by adolescent
mice when compared to adults in session 2 of the present study.
The link between mesoaccumbens dopaminergic activity and
motivational behavior is robust in both human and animal literature.
Locomotor behavior serves as the primary indicator of a dopaminergic-
related incentive state in rodents (Robinson and Berridge, 1993;
Wahlstrom et al., 2010). Taken as a whole, our data suggest that
adolescent mice are more sensitive than adults to both the acute and
sensitizedmotivational behavioral effects induced by the dopaminergic
agent amphetamine. Our ﬁndings also indicate a complex interaction
between the effects of environmental novelty, adolescence and
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